www.beigene.com Open in urlscan Pro
34.199.146.246  Public Scan

Form analysis
2 forms found in the DOM

GET https://www.beigene.com/

<form role="search" method="get" action="https://www.beigene.com/">
  <input type="search" class="form-control" placeholder="Search" name="s" value="" title="Search">
</form>

GET https://www.beigene.com/

<form role="search" method="get" action="https://www.beigene.com/">
  <input type="search" class="form-control" placeholder="Search" name="s" value="" title="Search">
</form>

Text Content

 * * Australia
   * Austria
   * Canada EN|FR
   * China
   * Germany
   * Global
   * Netherlands
   * South Korea
   * Spain
   * US


 * Our Purpose
   * Innovating Sustainably
   * Operating Responsibly
   * ESG Report & Goals
   * BeiGene Foundation
 * Our Science & Medicines
   * Our Research & Development
   * Pipeline
   * Our Medicines
   * Our Clinical Trials
   * Becoming an Investigator
   * Manufacturing
   * Our Products
 * For Patients
   * Global Patient Safety
   * Expanded Access Programs
   * Cancer & Mental Health
 * Our Company & People
   * Our Mission, Vision & Values
   * Our History
   * Leadership & Board
   * Diversity, Equity, Inclusion & Belonging
   * Join Our Team
   * Meet BeiGene

--------------------------------------------------------------------------------

 * Investors
   * NASDAQ Investors
   * HKEX Investors
   * SSE Investors
 * News & Media
 * Partnering
 * Medical Info
 * Suppliers
 * Careers
 * Contact Us

 * Global
   * Australia
   * Austria
   * Canada EN|FR
   * China
   * Germany
   * Global
   * Netherlands
   * South Korea
   * Spain
   * US

 * Investors
   * NASDAQ Investors
   * HKEX Investors
   * SSE Investors
 * News & Media
 * Partnering
 * Medical Info
 * Suppliers
 * Careers
 * Contact Us



 * Our Purpose
   * Innovating Sustainably
   * Operating Responsibly
   * ESG Report & Goals
   * BeiGene Foundation
 * Our Science & Medicines
   * Our Research & Development
   * Pipeline
   * Our Medicines
   * Our Clinical Trials
   * Becoming an Investigator
   * Manufacturing
   * Our Products
 * For Patients
   * Global Patient Safety
   * Expanded Access Programs
   * Cancer & Mental Health
 * Our Company & People
   * Our Mission, Vision & Values
   * Our History
   * Leadership & Board
   * Diversity, Equity, Inclusion & Belonging
   * Join Our Team
   * Meet BeiGene


CANCER HAS NO BORDERS. NEITHER DO WE.

We transcend borders, time zones, and especially the status quo to develop
therapies that are more accessible to people around the world.

Learn More

We transcend borders, time zones, and especially the status quo to develop
therapies that are more accessible to people around the world.

Learn More


PUTTING PATIENTS FIRST

We offer resources to help patients and their loved ones navigate some of the
complex challenges that follow the words, “You have cancer.”

Learn More




SCIENCE-BASED, PASSION-DRIVEN

We are advancing an innovative, high-value product portfolio for patients
globally.

Learn More




PASSION WITH PURPOSE

We work to benefit patients wherever they live by uniting worldwide talent and
resources with our vision.

Learn More






BEIGENE NEWS

January 18, 2023

BEIGENE ANNOUNCES EXPANSION OF COVERAGE ON CHINA’S NATIONAL REIMBURSEMENT DRUG
LIST

Read more

January 17, 2023

BEIGENE PRESENTS NEW RESEARCH FROM TISLELIZUMAB GLOBAL DEVELOPMENT PROGRAM AT
2023 ASCO GASTROINTESTINAL CANCERS SYMPOSIUM

Read more

January 4, 2023

BEIGENE TO PRESENT AT THE J.P. MORGAN 41ST ANNUAL HEALTHCARE CONFERENCE

Read more

December 30, 2022

BEIGENE ANNOUNCES ACCEPTANCE OF 12TH REGULATORY SUBMISSION IN CHINA FOR PD-1
INHIBITOR TISLELIZUMAB

Read more

January 19, 2023

BRUKINSA® APPROVED IN THE U.S. FOR CHRONIC LYMPHOCYTIC LEUKEMIA

Read more

January 19, 2023

BRUKINSA® (ZANUBRUTINIB) RECEIVES MARKETING AUTHORIZATION FOR CHRONIC
LYMPHOCYTIC LEUKEMIA (CLL) AND MARGINAL ZONE LYMPHOMA (MZL) IN GREAT BRITAIN BY
MHRA

Read more

January 18, 2023

BEIGENE ANNOUNCES EXPANSION OF COVERAGE ON CHINA’S NATIONAL REIMBURSEMENT DRUG
LIST

Read more

January 17, 2023

BEIGENE PRESENTS NEW RESEARCH FROM TISLELIZUMAB GLOBAL DEVELOPMENT PROGRAM AT
2023 ASCO GASTROINTESTINAL CANCERS SYMPOSIUM

Read more

January 4, 2023

BEIGENE TO PRESENT AT THE J.P. MORGAN 41ST ANNUAL HEALTHCARE CONFERENCE

Read more

December 30, 2022

BEIGENE ANNOUNCES ACCEPTANCE OF 12TH REGULATORY SUBMISSION IN CHINA FOR PD-1
INHIBITOR TISLELIZUMAB

Read more

January 19, 2023

BRUKINSA® APPROVED IN THE U.S. FOR CHRONIC LYMPHOCYTIC LEUKEMIA

Read more

January 19, 2023

BRUKINSA® (ZANUBRUTINIB) RECEIVES MARKETING AUTHORIZATION FOR CHRONIC
LYMPHOCYTIC LEUKEMIA (CLL) AND MARGINAL ZONE LYMPHOMA (MZL) IN GREAT BRITAIN BY
MHRA

Read more

January 18, 2023

BEIGENE ANNOUNCES EXPANSION OF COVERAGE ON CHINA’S NATIONAL REIMBURSEMENT DRUG
LIST

Read more

January 17, 2023

BEIGENE PRESENTS NEW RESEARCH FROM TISLELIZUMAB GLOBAL DEVELOPMENT PROGRAM AT
2023 ASCO GASTROINTESTINAL CANCERS SYMPOSIUM

Read more


 * Our Purpose
 * Our Science & Medicines
 * For Patients
 * Our Company & People

 * Investors
 * News & Media
 * Partnering
 * Medical Info
 * Suppliers
 * Careers
 * Contact Us

 * Privacy
 * Accessibility
 * Terms of Use
 * Sitemap

 * Twitter
 * LinkedIn
 * YouTube

© 2023 BeiGene, Inc.

Cookies Button

By clicking “Accept All Cookies”, you agree to the storing of cookies on your
device to enhance site navigation, analyze site usage, and assist in our
marketing efforts. For more information on our cookies policy or how BeiGene
processes your personal information, please see ourPrivacy Policy.

Accept All Cookies
Select Cookies



PRIVACY PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
More information
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms.    You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work. These cookies do not store any personally identifiable information.

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages.    If you do not allow these cookies then
some or all of these services may not function properly.

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites.    They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site.    All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

Back Button


BACK



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Confirm My Choices